76H-11978-08074
3 vaccinations
2 coded responses
24 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 462 / IN
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Registered dependents
9LE-29994-09512
Child or adolescent in my care · Female · 2022-07-13
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2021-01-10
Registered in v-safe
-
2021-01-10
Dose 2 — Pfizer-BioNTech
- 2021-01-10
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-24
- 2021-01-31
-
2021-02-07
Survey response — day 28, dose 2MedDRA: Menstrual disorder, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: Abnormal menstrual bleeding since first vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-14
- 2021-02-21
- 2021-04-11
- 2021-07-11
-
2021-09-24
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-03
- 2021-10-10
- 2021-10-17
- 2021-10-22
- 2021-10-29
-
2021-11-05
Survey response — day 42, dose 3MedDRA: Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-08
- 2021-12-24
- 2022-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-11 | priority 2/3 | |
| 2021-11-05 | Unsuccessful |
Free text
Release 3 — day 28, dose 2
Symptoms: Abnormal menstrual bleeding since first vaccine
Release 10 — day 42, dose 3
Symptoms: Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Reaction to previous exposure to any vaccine | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release